Galeota James JR 4
4 · MELINTA THERAPEUTICS, INC. /NEW/ · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Galeota James JR
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-12+9,100→ 9,100 totalExercise: $7.45From: 2019-04-20Exp: 2028-04-20→ Common Stock (9,100 underlying) - Award
Stock Option (right to buy)
2018-06-12+25,000→ 25,000 totalExercise: $7.45Exp: 2028-04-20→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the Company's board of directors on April 20, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on June 12, 2018.
- [F2]One-third of the shares underlying the stock option will vest and become exercisable on April 20, 2019. The remainder will vest and become exercisable in substantially equal monthly installments during the two year period commencing on April 20, 2019.